Coherus BioSciences
(NASDAQ:CHRS)
$2.38
-0.04[-1.65%]
At close: Mar 28
$2.38
0[0.00%]
After Hours: 7:54PM EDT
Consensus Rating1
Buy
Highest Price Target1
$21.00
Lowest Price Target1
$7.00
Consensus Price Target1
$10.00

Coherus BioSciences Stock (NASDAQ:CHRS), Analyst Ratings, Price Targets, Predictions

Coherus BioSciences Inc has a consensus price target of $10, established from looking at the 39 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Baird on March 20, 2024, March 14, 2024, and January 23, 2024. With an average price target of $11 between HC Wainwright & Co., HC Wainwright & Co., and Baird, there's an implied 362.18% upside for Coherus BioSciences Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
Nov 23
3
Dec 23
2
Jan
2
Mar
2
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Baird
Truist Securities
Maxim Group
Barclays

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Coherus BioSciences

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
03/20/2024CHRSBuy Now
Coherus BioSciences
$2.38362.18%HC Wainwright & Co.
Douglas Tsao
$13 → $11MaintainsBuyGet Alert
03/14/2024CHRSBuy Now
Coherus BioSciences
$2.38446.22%HC Wainwright & Co.
Douglas Tsao
→ $13ReiteratesBuy → BuyGet Alert
01/23/2024CHRSBuy Now
Coherus BioSciences
$2.38278.15%Baird
Colleen Kusy
$11 → $9MaintainsOutperformGet Alert
01/23/2024CHRSBuy Now
Coherus BioSciences
$2.38236.13%Truist Securities
Robyn Karnauskas
$12 → $8MaintainsBuyGet Alert
12/27/2023CHRSBuy Now
Coherus BioSciences
$2.38446.22%HC Wainwright & Co.
Douglas Tsao
→ $13ReiteratesBuy → BuyGet Alert
12/07/2023CHRSBuy Now
Coherus BioSciences
$2.38446.22%HC Wainwright & Co.
Douglas Tsao
→ $13ReiteratesBuy → BuyGet Alert
11/28/2023CHRSBuy Now
Coherus BioSciences
$2.38404.2%Truist Securities
Robyn Karnauskas
→ $12ReiteratesBuy → BuyGet Alert
11/17/2023CHRSBuy Now
Coherus BioSciences
$2.38362.18%Baird
Colleen Kusy
→ $11Initiates → OutperformGet Alert
11/08/2023CHRSBuy Now
Coherus BioSciences
$2.38Maxim Group
Jason McCarthy
DowngradeBuy → HoldGet Alert
11/07/2023CHRSBuy Now
Coherus BioSciences
$2.38446.22%HC Wainwright & Co.
Douglas Tsao
$20 → $13MaintainsBuyGet Alert
10/23/2023CHRSBuy Now
Coherus BioSciences
$2.38194.12%Barclays
Balaji Prasad
$8 → $7MaintainsOverweightGet Alert
09/26/2023CHRSBuy Now
Coherus BioSciences
$2.38740.34%Truist Securities
Robyn Karnauskas
→ $20ReiteratesBuy → BuyGet Alert
09/26/2023CHRSBuy Now
Coherus BioSciences
$2.38740.34%HC Wainwright & Co.
Douglas Tsao
→ $20ReiteratesBuy → BuyGet Alert
08/03/2023CHRSBuy Now
Coherus BioSciences
$2.38740.34%HC Wainwright & Co.
Douglas Tsao
$24 → $20MaintainsBuyGet Alert
07/24/2023CHRSBuy Now
Coherus BioSciences
$2.38404.2%Citigroup
Robyn Karnauskas
→ $12Initiates → BuyGet Alert
07/14/2023CHRSBuy Now
Coherus BioSciences
$2.38740.34%Truist Securities
Robyn Karnauskas
$22 → $20MaintainsBuyGet Alert
06/28/2023CHRSBuy Now
Coherus BioSciences
$2.38824.37%Truist Securities
Robyn Karnauskas
→ $22ReiteratesBuy → BuyGet Alert
06/20/2023CHRSBuy Now
Coherus BioSciences
$2.38824.37%Truist Securities
Robyn Karnauskas
$24 → $22MaintainsBuyGet Alert
06/20/2023CHRSBuy Now
Coherus BioSciences
$2.38908.4%HC Wainwright & Co.
Douglas Tsao
→ $24ReiteratesBuy → BuyGet Alert

FAQ

Q

What is the target price for Coherus BioSciences (CHRS)?

A

The latest price target for Coherus BioSciences (NASDAQ: CHRS) was reported by HC Wainwright & Co. on March 20, 2024. The analyst firm set a price target for $11.00 expecting CHRS to rise to within 12 months (a possible 362.18% upside). 25 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Coherus BioSciences (CHRS)?

A

The latest analyst rating for Coherus BioSciences (NASDAQ: CHRS) was provided by HC Wainwright & Co., and Coherus BioSciences maintained their buy rating.

Q

When was the last upgrade for Coherus BioSciences (CHRS)?

A

The last upgrade for Coherus BioSciences Inc happened on March 28, 2023 when UBS raised their price target to $11. UBS previously had a neutral for Coherus BioSciences Inc.

Q

When was the last downgrade for Coherus BioSciences (CHRS)?

A

The last downgrade for Coherus BioSciences Inc happened on November 8, 2023 when Maxim Group changed their price target from N/A to N/A for Coherus BioSciences Inc.

Q

When is the next analyst rating going to be posted or updated for Coherus BioSciences (CHRS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Coherus BioSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Coherus BioSciences was filed on March 20, 2024 so you should expect the next rating to be made available sometime around March 20, 2025.

Q

Is the Analyst Rating Coherus BioSciences (CHRS) correct?

A

While ratings are subjective and will change, the latest Coherus BioSciences (CHRS) rating was a maintained with a price target of $13.00 to $11.00. The current price Coherus BioSciences (CHRS) is trading at is $2.38, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch